Burning Rock Biotech Limited
BNR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $51 | $70 | $161 | $631 |
| - Cash | $520 | $615 | $905 | $1,431 |
| + Debt | $52 | $12 | $51 | $87 |
| Enterprise Value | -$417 | -$532 | -$693 | -$714 |
| Revenue | $516 | $537 | $563 | $508 |
| % Growth | -4% | -4.6% | 10.9% | – |
| Gross Profit | $362 | $363 | $380 | $364 |
| % Margin | 70.3% | 67.6% | 67.5% | 71.7% |
| EBITDA | -$270 | -$518 | -$856 | -$746 |
| % Margin | -52.4% | -96.4% | -152% | -147% |
| Net Income | -$347 | -$654 | -$971 | -$797 |
| % Margin | -67.2% | -121.6% | -172.4% | -156.9% |
| EPS Diluted | -33.67 | -63.84 | -93.47 | -76.45 |
| % Growth | 47.3% | 31.7% | -22.3% | – |
| Operating Cash Flow | -$92 | -$256 | -$457 | -$478 |
| Capital Expenditures | -$6 | -$9 | -$62 | -$213 |
| Free Cash Flow | -$98 | -$265 | -$519 | -$691 |